213 related articles for article (PubMed ID: 9262322)
1. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats.
Cabral AM; Varner KJ; Kapusta DR
J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322
[TBL] [Abstract][Full Text] [Related]
2. Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia.
Cabral AD; Kapusta DR; Kenigs VA; Varner KJ
Am J Physiol; 1998 Dec; 275(6):R1867-74. PubMed ID: 9843875
[TBL] [Abstract][Full Text] [Related]
3. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
[TBL] [Abstract][Full Text] [Related]
4. Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1995 Apr; 273(1):199-205. PubMed ID: 7714767
[TBL] [Abstract][Full Text] [Related]
5. Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats.
Sezen SF; Kenigs VA; Kapusta DR
J Pharmacol Exp Ther; 1998 Oct; 287(1):238-45. PubMed ID: 9765343
[TBL] [Abstract][Full Text] [Related]
6. Central mu opioid receptor-mediated changes in renal function in conscious rats.
Kapusta DR; Obih JC; Dibona GF
J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
[TBL] [Abstract][Full Text] [Related]
7. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
8. Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1989 Oct; 251(1):230-7. PubMed ID: 2552076
[TBL] [Abstract][Full Text] [Related]
9. Role of intrarenal alpha(2)-adrenoceptors in the renal responses to xylazine in rats.
Menegaz RG; Kapusta DR; Cabral AM
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R1074-81. PubMed ID: 10749797
[TBL] [Abstract][Full Text] [Related]
10. Central mu opioids mediate differential control of urine flow rate and urinary sodium excretion in conscious rats.
Kapusta DR; Dzialowski EM
Life Sci; 1995; 56(14):PL243-8. PubMed ID: 7475890
[TBL] [Abstract][Full Text] [Related]
11. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
[TBL] [Abstract][Full Text] [Related]
12. Activation of alpha(2)-receptors in the rostral ventrolateral medulla evokes natriuresis by a renal nerve mechanism.
Menegaz RG; Kapusta DR; Mauad H; de Melo Cabral A
Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R98-R107. PubMed ID: 11404283
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
[TBL] [Abstract][Full Text] [Related]
14. Preferable anesthetic conditions for echocardiographic determination of murine cardiac function.
Kawahara Y; Tanonaka K; Daicho T; Nawa M; Oikawa R; Nasa Y; Takeo S
J Pharmacol Sci; 2005 Sep; 99(1):95-104. PubMed ID: 16177543
[TBL] [Abstract][Full Text] [Related]
15. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of infusions of xylazine with ketamine or propofol to modulate recovery following sevoflurane anesthesia in horses.
Wagner AE; Mama KR; Steffey EP; Hellyer PW
Am J Vet Res; 2012 Mar; 73(3):346-52. PubMed ID: 22369525
[TBL] [Abstract][Full Text] [Related]
17. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
18. Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs.
Qi W; Smith FG
Exp Physiol; 2006 Sep; 91(5):877-85. PubMed ID: 16728455
[TBL] [Abstract][Full Text] [Related]
19. The use of injectable alphaxalone as a single agent and in combination with ketamine, xylazine, and morphine in the Chilean rose tarantula, Grammostola rosea.
Gjeltema J; Posner LP; Stoskopf M
J Zoo Wildl Med; 2014 Dec; 45(4):792-801. PubMed ID: 25632665
[TBL] [Abstract][Full Text] [Related]
20. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
Kapusta DR; Sezen SF; Chang JK; Lippton H; Kenigs VA
Life Sci; 1997; 60(1):PL15-21. PubMed ID: 8995537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
